BRCA Survey


This study is assessing the type of information, content and quality of physician-patient communication for individuals with BRCA 1 or 2 prescribed hormone replacement therapy (HRT) following a risk-reducing bilateral salpingo-oophorectomy (RR BSO). The type and quality of information by physicians will provide insight into the factors used for HRT treatment decisions. The survey questions assess respondent demographics, personal and family histories, the decision for hormone or estrogen replacement, communication content and quality, and counseling received by healthcare providers. 

Hello members of BRCA Support Facebook Groups. Please consider completing the following survey about hormonal replacement treatment (HRT) after risk reducing bilateral salpingo-oophorectomy (RR BSO). We hope to improve physician practices in patient care, education, and shared-decision making. Your responses will remain confidential and the survey responses will not be linked back to the Facebook group to maintain anonymity.

It will take no more than 10 minutes to complete the survey.

A note on privacy
This survey is anonymous.
The record of your survey responses does not contain any identifying information about you, unless a specific survey question explicitly asked for it. If you used an identifying token to access this survey, please rest assured that this token will not be stored together with your responses. It is managed in a separate database and will only be updated to indicate whether you did (or did not) complete this survey. There is no way of matching identification tokens with survey responses.